AG
IMA

Artal Group’s ImageneBio Inc IMA Stock Holding History

Artal Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-83,293
Closed -$1.97M – 116
2023
Q4 		$1.97M Sell
83,293
-70,833
-46% -$2.31M 0.07% 65
2023
Q3 		$8.01M Hold
154,126
– – 0.34% 48
2023
Q2 		$12.1M Buy
154,126
+25,000
+19% +$1.79M 0.38% 39
2023
Q1 		$5.35M Hold
129,126
– – 0.32% 60
2022
Q4 		$4.12M Hold
129,126
– – 0.23% 68
2022
Q3 		$5.5M Hold
129,126
– – 0.23% 56
2022
Q2 		$6.86M Hold
129,126
– – 0.37% 46
2022
Q1 		$9.45M Hold
129,126
– – 0.4% 48
2021
Q4 		$19.4M Hold
129,126
– – 0.53% 49
2021
Q3 		$19.6M Hold
129,126
– – 0.44% 54
2021
Q2 		$21.8M Hold
129,126
– – 0.44% 51
2021
Q1 		$43.8M Buy
+129,126
New +$44.2M 0.77% 29

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artal Group's IMA Position: Q1 2024 in Review

Artal Group sold out of ImageneBio Inc (IMA) in Q1 2024, closing a stake of 83,293 shares — an estimated $1.97M sold.

Artal Group first reported a position in IMA in Q1 2021 and held it in 12 quarters. The position peaked at $43.8M in Q1 2021. 55 funds tracked by Wall St. Rank hold IMA as of Q1 2024.

  • Artal Group reported no remaining ImageneBio Inc position as of Q1 2024 after selling out during the quarter.
  • Artal Group sold 83,293 ImageneBio Inc shares in Q1 2024, an estimated $1.97M.
  • Artal Group first reported a position in ImageneBio Inc in Q1 2021 and held it in 12 quarters.
  • Artal Group's ImageneBio Inc position peaked at $43.8M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2024.

Based on Artal Group's 13F filing for Q1 2024, filed 13 May 2024.